Detalles de la búsqueda
1.
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
Br J Cancer
; 130(5): 769-776, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184691
2.
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Strahlenther Onkol
; 199(10): 901-909, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256301
3.
[18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer.
Eur J Nucl Med Mol Imaging
; 50(2): 559-571, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36282298
4.
Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis.
World J Urol
; 41(3): 641-651, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35835886
5.
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
World J Urol
; 41(8): 2033-2041, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484817
6.
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
Acta Oncol
; 62(6): 648-656, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338525
7.
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
World J Urol
; 40(12): 2931-2937, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342512
8.
Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic).
World J Urol
; 40(2): 419-425, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34773475
9.
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Lancet Oncol
; 20(12): 1740-1749, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31629656
10.
Salvage extended field or involved field nodal irradiation in 18F-fluorocholine PET/CT oligorecurrent nodal failures from prostate cancer.
Eur J Nucl Med Mol Imaging
; 46(1): 40-48, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267117
11.
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.
Acta Oncol
; 57(4): 491-497, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28853615
12.
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.
Prostate
; 77(10): 1160-1166, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28594087
13.
Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE).
BMC Cancer
; 17(1): 483, 2017 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28705182
14.
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Lancet Oncol
; 17(6): 747-756, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160475
15.
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
Lancet Oncol
; 15(3): 305-14, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24556041
16.
Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity.
Cancer Treat Rev
; 124: 102684, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38278078
17.
Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure.
Int J Radiat Biol
; 100(1): 79-86, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526368
18.
PARP inhibitors in prostate cancers, is it time for combinations?
Ther Adv Med Oncol
; 16: 17588359241242959, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38827177
19.
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Eur Urol
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490854
20.
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.
Eur Urol Oncol
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734543